Cargando…

Improved Histone Deacetylase Inhibitors as Therapeutics for the Neurodegenerative Disease Friedreich's Ataxia: A New Synthetic Route

Friedreich's ataxia (FRDA) is caused by transcriptional repression of the nuclear FXN gene encoding the essential mitochondrial protein frataxin. Based on the hypothesis that the acetylation state of the histone proteins is responsible for gene silencing in FRDA, previous work in our lab identi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Chunping, Soragni, Elisabetta, Jacques, Vincent, Rusche, James R., Gottesfeld, Joel M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060102/ https://www.ncbi.nlm.nih.gov/pubmed/27721337 http://dx.doi.org/10.3390/ph4121578

Ejemplares similares

Mechanism of Action of 2-Aminobenzamide HDAC Inhibitors in Reversing Gene Silencing in Friedreich’s Ataxia
por: Soragni, Elisabetta, et al.
Publicado: (2015)

Two New Pimelic Diphenylamide HDAC Inhibitors Induce Sustained Frataxin Upregulation in Cells from Friedreich's Ataxia Patients and in a Mouse Model
por: Rai, Myriam, et al.
Publicado: (2010)

HDAC Inhibitors Correct Frataxin Deficiency in a Friedreich Ataxia Mouse Model
por: Rai, Myriam, et al.
Publicado: (2008)

Methylated and unmethylated epialleles support variegated epigenetic silencing in Friedreich ataxia
por: Rodden, Layne N, et al.
Publicado: (2021)

Long intronic GAA•TTC repeats induce epigenetic changes and reporter gene silencing in a molecular model of Friedreich ataxia
por: Soragni, E., et al.
Publicado: (2008)

The Effects of Pharmacological Inhibition of Histone Deacetylase 3 (HDAC3) in Huntington’s Disease Mice
por: Jia, Haiqun, et al.
Publicado: (2016)

Reversal of epigenetic promoter silencing in Friedreich ataxia by a class I histone deacetylase inhibitor
por: Chutake, Yogesh K., et al.
Publicado: (2016)

Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse model
por: Sandi, Chiranjeevi, et al.
Publicado: (2011)

Quantitative Proteomic Analysis Identifies Targets and Pathways of a 2-Aminobenzamide HDAC Inhibitor in Friedreich’s Ataxia Patient iPSC-Derived Neural Stem Cells
por: Shan, Bing, et al.
Publicado: (2014)

Ferroptosis in Friedreich’s Ataxia: A Metal-Induced Neurodegenerative Disease
por: La Rosa, Piergiorgio, et al.
Publicado: (2020)

A non-synonymous single nucleotide polymorphism in SIRT6 predicts neurological severity in Friedreich ataxia
por: Rodden, Layne N., et al.
Publicado: (2022)

Friedreich's Ataxia
por: Anderson, J. Wallace
Publicado: (1893)

The Pathology of Friedreich's Ataxia
por: Rainy, Harry
Publicado: (1905)

Neuroinflammation in Friedreich’s Ataxia
por: Apolloni, Savina, et al.
Publicado: (2022)

Development of Frataxin Gene Expression Measures for the Evaluation of Experimental Treatments in Friedreich’s Ataxia
por: Plasterer, Heather L., et al.
Publicado: (2013)

Erythropoietin and Friedreich Ataxia: Time for a Reappraisal?
por: Boesch, Sylvia, et al.
Publicado: (2019)

Autonomic function testing in Friedreich’s ataxia
por: Indelicato, Elisabetta, et al.
Publicado: (2018)

Synthetic Routes and Biological Evaluation of Largazole and Its Analogues as Potent Histone Deacetylase Inhibitors
por: Li, Shang, et al.
Publicado: (2011)

Central Nervous System Therapeutic Targets in Friedreich Ataxia
por: Harding, Ian H., et al.
Publicado: (2020)

Is Friedreich ataxia an epigenetic disorder?
por: Kumari, Daman, et al.
Publicado: (2012)

The Pathogenesis of Cardiomyopathy in Friedreich Ataxia
por: Koeppen, Arnulf H., et al.
Publicado: (2015)

Depressive symptoms in Friedreich ataxia
por: Nieto, Antonieta, et al.
Publicado: (2018)

Heart disease in Friedreich’s ataxia
por: Hanson, Emily, et al.
Publicado: (2019)

Drug Repositioning in Friedreich Ataxia
por: Rufini, Alessandra, et al.
Publicado: (2022)

Two Cases of Friedreich’s Ataxia
por: Stephenson, F. H.
Publicado: (1897)

Respiratory Function in Friedreich’s Ataxia
por: Vinante, Elena, et al.
Publicado: (2022)

Selected Histone Deacetylase Inhibitors Reverse the Frataxin Transcriptional Defect in a Novel Friedreich’s Ataxia Induced Pluripotent Stem Cell-Derived Neuronal Reporter System
por: Schreiber, Anna M., et al.
Publicado: (2022)

Friedreich ataxia in a family from Mali, West Africa/Friedreich ataxia in a Malian family
por: Cissé, Cheick A. K., et al.
Publicado: (2021)

Onset features and time to diagnosis in Friedreich’s Ataxia
por: Indelicato, Elisabetta, et al.
Publicado: (2020)

HMTase Inhibitors as a Potential Epigenetic-Based Therapeutic Approach for Friedreich’s Ataxia
por: Sherzai, Mursal, et al.
Publicado: (2020)

Anaesthesia for a patient with Friedreich's ataxia
por: Ganesan, Ilango
Publicado: (2011)

Hepatic mitochondrial dysfunction in Friedreich Ataxia
por: Stüwe, Sven H, et al.
Publicado: (2011)

Epigenetic-based therapies for Friedreich ataxia
por: Sandi, Chiranjeevi, et al.
Publicado: (2014)

Identification of telomere dysfunction in Friedreich ataxia
por: Anjomani Virmouni, Sara, et al.
Publicado: (2015)

Otoneurological Abnormalities in Patients with Friedreich's Ataxia
por: Zeigelboim, Bianca Simone, et al.
Publicado: (2016)

The role of oxidative stress in Friedreich's ataxia
por: Lupoli, Federica, et al.
Publicado: (2017)

Two Cases of Friedreich's Ataxia in Adolescents
por: Fergus, John
Publicado: (1917)

Drosophila melanogaster Models of Friedreich's Ataxia
por: Calap-Quintana, P., et al.
Publicado: (2018)

An Overview of the Ferroptosis Hallmarks in Friedreich’s Ataxia
por: Turchi, Riccardo, et al.
Publicado: (2020)

Predictors of loss of ambulation in Friedreich's ataxia
por: Rummey, Christian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lk3iscg32su5h788pu757uilu0